Trademark Overview
On Monday, November 3, 2025, a trademark application was filed for MARUX CONTINUOUS BIOMANUFACTURING with the United States Patent and Trademark Office. The USPTO has given the MARUX CONTINUOUS BIOMANUFACTURING trademark a serial number of 79441470. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 15, 2026. This trademark is owned by Fujifilm Diosynth Biotechnologies UK Limited. The MARUX CONTINUOUS BIOMANUFACTURING trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Continuous production, including continuous manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous expression, isolation and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous connected upstream and downstream production of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others.
Scientific, industrial and technical research, development and analysis services related to continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; industrial design services related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; provision of facilities for scientific, industrial and technical research development related to the continuous production, including continuous manufacture and purification, of biological products such a...
